"
Team:HZAU-China/Project/Bacterial Spores as Vaccine Vehicles
From 2013.igem.org
(Difference between revisions)
| (6 intermediate revisions not shown) | |||
| Line 38: | Line 38: | ||
ul.menu:after{content:"";display:block;height:0;clear:both;visibility:hidden;} | ul.menu:after{content:"";display:block;height:0;clear:both;visibility:hidden;} | ||
ul.menu, | ul.menu, | ||
| - | ul.menu ul {padding:0;margin:0;list-style:none;position:;width:220px;background:# | + | ul.menu ul {padding:0;margin:0;list-style:none;position:;width:220px;background:#d3f18c;font-family:arial, sans-serif;} |
ul.menu {z-index:100;padding:10px;margin:0 auto;} | ul.menu {z-index:100;padding:10px;margin:0 auto;} | ||
ul.menu ul {z-index:50; | ul.menu ul {z-index:50; | ||
| Line 50: | Line 50: | ||
ul.menu > li {margin-top:2px;font-size:12px;} | ul.menu > li {margin-top:2px;font-size:12px;} | ||
ul.menu > li a {font:normal 16px/29px arial, sans-serif;color:#fff;text-decoration:none;} | ul.menu > li a {font:normal 16px/29px arial, sans-serif;color:#fff;text-decoration:none;} | ||
| - | ul.menu label.open {display:block;background:# | + | ul.menu label.open {display:block;background:#517b1f no-repeat 170px 12px;line-height:30px;position:relative;z- |
| - | + | ||
index:100;font:normal 12px/30px arial, sans-serif;color:#fff;border-radius:10px 10px 0 0;} | index:100;font:normal 12px/30px arial, sans-serif;color:#fff;border-radius:10px 10px 0 0;} | ||
| - | + | ul.menu span {display:block;background:#517b1f;line-height:30px;position:relative;z-index:100;font-size: 16px;padding-left:10px;} | |
| - | ul.menu span {display:block;background:# | + | |
ul.menu label img {position:absolute;left:0;top:0;width:100%;height:30px;} | ul.menu label img {position:absolute;left:0;top:0;width:100%;height:30px;} | ||
ul.menu ul li {margin-top:-30px; | ul.menu ul li {margin-top:-30px; | ||
| Line 63: | Line 61: | ||
transition: 0.5s; | transition: 0.5s; | ||
} | } | ||
| - | ul.menu ul li a {display:block;font:normal 16px/29px arial, sans-serif;color:#000;background:# | + | ul.menu ul li a {display:block;font:normal 16px/29px arial, sans-serif;color:#000;background:#b3e24b;} |
| - | ul.menu ul li a:hover {background:# | + | ul.menu ul li a:hover {background:#d3f18c;} |
ul.menu input {position:absolute;left:-9999px;} | ul.menu input {position:absolute;left:-9999px;} | ||
ul.menu li input:checked + label {background:#069;} | ul.menu li input:checked + label {background:#069;} | ||
| - | ul.menu li input:checked ~ ul {background:# | + | ul.menu li input:checked ~ ul {background:#b3e24b;padding-bottom:10px;} |
ul.menu li input:checked ~ ul li {margin-top:0;} | ul.menu li input:checked ~ ul li {margin-top:0;} | ||
ul.menu label.close {display:block;width:200px;height:30px;background:transparent url("/jscss/demoimg/201208/u-arrow.gif") | ul.menu label.close {display:block;width:200px;height:30px;background:transparent url("/jscss/demoimg/201208/u-arrow.gif") | ||
| Line 99: | Line 97: | ||
<li><a href="https://2013.igem.org/Team:HZAU-China/Project"><span>Overview</span></a></li> | <li><a href="https://2013.igem.org/Team:HZAU-China/Project"><span>Overview</span></a></li> | ||
<li><a href="https://2013.igem.org/Team:HZAU-China/Project/The innovation of HZAU-iGEM Team"><span>The innovation of HZAU-iGEM Team</span></a></li> | <li><a href="https://2013.igem.org/Team:HZAU-China/Project/The innovation of HZAU-iGEM Team"><span>The innovation of HZAU-iGEM Team</span></a></li> | ||
| + | <li><a href="https://2013.igem.org/Team:HZAU-China/Project/The design of experiment"><span>The design of experiment</span></a></li> | ||
<li><a href="https://2013.igem.org/Team:HZAU-China/Project/Rabies"><span>Rabies</span></a></li> | <li><a href="https://2013.igem.org/Team:HZAU-China/Project/Rabies"><span>Rabies</span></a></li> | ||
<li><a href="https://2013.igem.org/Team:HZAU-China/Project/Flea and Yersinia pestis"><span>Flea and Yersinia pestis</span></a></li> | <li><a href="https://2013.igem.org/Team:HZAU-China/Project/Flea and Yersinia pestis"><span>Flea and Yersinia pestis</span></a></li> | ||
| Line 104: | Line 103: | ||
<li><a href="https://2013.igem.org/Team:HZAU-China/Project/Bacillus subtilis as Probiotics"><span>Bacillus subtilis as Probiotics</span></a></li> | <li><a href="https://2013.igem.org/Team:HZAU-China/Project/Bacillus subtilis as Probiotics"><span>Bacillus subtilis as Probiotics</span></a></li> | ||
<li><a href="https://2013.igem.org/Team:HZAU-China/Project/Antimicrobial Peptides"><span>Antimicrobial Peptides</span></a></li> | <li><a href="https://2013.igem.org/Team:HZAU-China/Project/Antimicrobial Peptides"><span>Antimicrobial Peptides</span></a></li> | ||
| - | <li><a href="https://2013.igem.org/Team:HZAU-China/Project/ | + | <li><a href="https://2013.igem.org/Team:HZAU-China/Project/Methods for rearing flea"><span>Methods for rearing flea</span></a></li> |
| - | + | ||
</body> | </body> | ||
</div> | </div> | ||
<div id="paragraphs"> | <div id="paragraphs"> | ||
| + | <p><br></p> | ||
| + | <center> | ||
| + | <span style="font-size:40px;font-family:Cambria;margin-top:10px;line-height:80%">Bacterial Spores as Vaccine Vehicles</span> | ||
| + | </center> | ||
| + | <p><br></p> | ||
| + | |||
<p style="font-size:16px;font-family:arial, sans-serif;">Bacillus subtilis has been explored as a host for the expression of foreign genes with immunological activities. The following are main reasons:</p> | <p style="font-size:16px;font-family:arial, sans-serif;">Bacillus subtilis has been explored as a host for the expression of foreign genes with immunological activities. The following are main reasons:</p> | ||
<p style="font-size:16px;font-family:arial, sans-serif;">1.As gram-positive bacteria, B.subtilis strains do not have an outer membrane, which is appropriate for secreting proteins directly into medium.</p> | <p style="font-size:16px;font-family:arial, sans-serif;">1.As gram-positive bacteria, B.subtilis strains do not have an outer membrane, which is appropriate for secreting proteins directly into medium.</p> | ||
| Line 117: | Line 121: | ||
<p style="text-align:center;"><a><img width="710" src="https://static.igem.org/mediawiki/igem.org/9/93/6_%E5%89%AF%E6%9C%AC.png" ></a></br></p> | <p style="text-align:center;"><a><img width="710" src="https://static.igem.org/mediawiki/igem.org/9/93/6_%E5%89%AF%E6%9C%AC.png" ></a></br></p> | ||
| - | <p style="font-size:13px;font-family:arial, sans-serif;"> | + | <p style="font-size:13px;font-family:arial, sans-serif;text-align:center;">The potential advantages for B.subitilis as vaccine vector. |
</p> | </p> | ||
| Line 126: | Line 130: | ||
<p style="font-size:16px;font-family:arial, sans-serif;"><b>In our experiment design, we choose the second one. Germinating spores can secrete antigen to host to induce immunity response.</b></p> | <p style="font-size:16px;font-family:arial, sans-serif;"><b>In our experiment design, we choose the second one. Germinating spores can secrete antigen to host to induce immunity response.</b></p> | ||
| + | |||
| + | <h3>Reference</h3> | ||
| + | |||
| + | <p style="font-size:16px;font-family:arial, sans-serif;">1. LUÍS C.S. FERREIRA, RITA C.C. FERREIRA1 and WOLFGANG SCHUMANN. Bacillus subtilis as a tool for vaccine development: from antigen factories to delivery vectors. Anais da academia Brasileira de Ciências, 2005;77(1): 113-124.</p> | ||
| + | <p style="font-size:16px;font-family:arial, sans-serif;">2. Wang CY, Zhang ZS. Bacteria spores. Acta Microbiologica Sinica, 2008;48(3):413-417</p> | ||
</div> | </div> | ||
Latest revision as of 04:05, 28 September 2013
Bacillus subtilis has been explored as a host for the expression of foreign genes with immunological activities. The following are main reasons:
1.As gram-positive bacteria, B.subtilis strains do not have an outer membrane, which is appropriate for secreting proteins directly into medium.
2.Similar to Ecolic and Yeast, the genetic knowledge and gene expression systems of B.subtilis strains are easier to get.
3.B.subtilis has received the GRAS(generally regarded as safe) status.
4.B.subtilis spores is the most resistant life form on earth and can exist under extreme environmental conditions , which makes the spore an attractive vector for delivering antigens. Meanwhile, B.subtilis spores is effective for oral antigen and can active mucosal immune response.
5.Non-biased codon usage and simply cultivate conditions make it a good candidate for the expression of heterologous proteins.
The potential advantages for B.subitilis as vaccine vector.
They are two ways for using B.subtilis as vaccine delivery vectors. One is the use of genetically modified B.subtilis spores expressing surface-exposed antigens fused to spore coat proteins. Another is focused on the production of recombinant antigens, which dependents on germinating spores.
The table shows some examples of vaccine application in humans.
In our experiment design, we choose the second one. Germinating spores can secrete antigen to host to induce immunity response.
Reference
1. LUÍS C.S. FERREIRA, RITA C.C. FERREIRA1 and WOLFGANG SCHUMANN. Bacillus subtilis as a tool for vaccine development: from antigen factories to delivery vectors. Anais da academia Brasileira de Ciências, 2005;77(1): 113-124.
2. Wang CY, Zhang ZS. Bacteria spores. Acta Microbiologica Sinica, 2008;48(3):413-417
